27
Participants
Start Date
February 1, 2025
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Dalfampridine
The study drug (4-AP) will be administered as a 10 mg dose twice a day.
Placebo
The placebo provided by the SRAL pharmacy that looks identical to the 4-AP, will be administered twice a day.
STDP stimulation
Paired stimulation will be given to the spinal cord and to peripheral nerves so that the signals are received at the spinal cord at a specific interval.
Exercise training
Lower-limb exercises will involve over-ground walking, treadmill, walking and stair climbing training.
RECRUITING
Shirley Ryan Abilitylab, Chicago
Shirley Ryan AbilityLab
OTHER